Sydnexis

Del Mar, United States

Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.

$45.0M raised

Aug 2021

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sydnexis raised?

Sydnexis has raised $45.0M in total funding. The most recent round was Series B. The last funding was announced in August 2021.

Who are Sydnexis's investors?

Sydnexis's investors include RA Capital Management, Longitude Capital, Medicxi, Visionary Venture Fund, SC Master Fund.

Where is Sydnexis headquartered?

Sydnexis is headquartered in Del Mar, United States.

What does Sydnexis do?

Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.

What stage is Sydnexis at?

Sydnexis is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 10, 2021.

MLA

"Sydnexis — Funding & Investors." VCBacked, August 10, 2021, https://www.vcbacked.co/company/sydnexis. Accessed July 1, 2026.

APA

VCBacked. (2021). Sydnexis — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/sydnexis

Wikipedia (cite web)

{{cite web |title=Sydnexis — Funding & Investors |url=https://www.vcbacked.co/company/sydnexis |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 10, 2021.